Cited by 219Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Is Alzheimer’s disease a systemic disease?

Open access
Morris, Jill K., Honea, Robyn A., Vidoni, Eric D., Swerdlow, Russell H., Burns, Jeffrey M.·2014·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Abstract

Although Alzheimer's disease (AD) is the most common neurodegenerative disease, the etiology of AD is not well understood. In some cases, genetic factors explain AD risk, but a high percentage of late-onset AD is unexplained. The fact that AD is associated with a number of physical and systemic manifestations suggests that AD is a multifactorial disease that affects both the CNS and periphery. Interestingly, a common feature of many systemic processes linked to AD is involvement in energy metabolism. The goals of this review are to 1) explore the evidence that peripheral processes contribute to AD risk, 2) explore ways that AD modulates whole-body changes, and 3) discuss the role of genetics, mitochondria, and vascular mechanisms as underlying factors that could mediate both central and peripheral manifestations of AD. Despite efforts to strictly define AD as a homogeneous CNS disease, there may be no single etiologic pathway leading to the syndrome of AD dementia. Rather, the neurodegenerative process may involve some degree of baseline genetic risk that is modified by external risk factors. Continued research into the diverse but related processes linked to AD risk is necessary for successful development of disease-modifying therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2014.04.012

Cites

229 of 229 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AD is being reframed as a systemic disorder linked to global aging processes rather than a purely localized brain disease.

    “Increasingly, AD is being reframed as a systemic disorder linked to global aging processes rather than a purely localized brain disease [4,5].”

    From Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease (2025) · cites this paper as [4]

    The Introduction contrasts the classical view of AD as a primary brain disease with evidence of early systemic manifestations. The Conclusions describe AD as a multifactorial disease affecting both the CNS and the body. The paper does not specifically characterize those shared processes as “global aging processes,” so that part of the claim is not established by this source. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Systemic inflammation is currently beginning to be considered a contributor to AD development.

    “In addition, not limited to neuroinflammatory response, systemic inflammation is currently beginning to be considered a contributor to AD development of AD [106, 107].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Research works printed but not linked: 3

  1. [83]Janson J Laedtke T Parisi JE Increased Risk of Type 2 Diabetes in Alzheimer Disease Diabetes 2004 53 2 474 481 14747300
  2. [126]BarrettConnor E Edelstein SL CoreyBloom J Weight loss precedes dementia in community-dwelling older adults Journal of the American Geriatrics Society 1996 44 10 1147 1152 8855991
  3. [151]Morris JK Vidoni ED Honea RA Burns JM Impaired glycemia increases disease progression in mild cognitive impairment Neurobiol Aging 2013 PMC3894574 24411018

Cited by

Sorted by citations

Authors
Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M.
Affiliations
University of Kansas (US)
Corresponding author
Burns, Jeffrey M.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2014-09
Volume
1842
Issue
9
Pages
1340-1349
ISSN
0925-4439 (ISSN-L)
OpenAlex
W1966802394
Cited by
219
References
229
Citations by year
2026: 12 · 2025: 12 · 2024: 9 · 2023: 21 · 2022: 21 · 2021: 26 · 2020: 25 · 2019: 20 · 2018: 21 · 2017: 17 · 2016: 16 · 2015: 18 · 2014: 1
FWCI
2.04
Type
journal article
Language
en
Open access
Locations
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Aging (F32AG044953, K01AG035042, KL2 TR000119, P30AG035982)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, systemic disease, energy metabolism, genetic risk, mitochondria, vascular mechanisms, multifactorial etiology, disease-modifying therapy, neurodegeneration
MeSH terms
Alzheimer Disease, Humans, Risk Factors, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review